Showing results (11-20 of 43) with videos related to
Sort By:
Pageof 5
Molecules (Basel, Switzerland)|February 25, 2022
Interaction Characterization of a Tyrosine Kinase Inhibitor Erlotinib with a Model Transport Protein in the Presence of Quercetin: A Drug-Protein and Drug-Drug Interaction Investigation Using Multi-Spectroscopic and Computational ApproachesTanveer A Wani, Mohammed M Alanazi, Nawaf A Alsaif, et al.Bioorganic Chemistry|March 12, 2022
Design, synthesis, antitumor, and VEGFR-2 inhibition activities of novel 4-anilino-2-vinyl-quinazolines: Molecular modeling studiesAbdelrahman Hamdi, Hamed W El-Shafey, Dina I A Othman, et al.Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society|October 20, 2023
Gastroprotective evaluation of <i>Medicago sativa</i> L. (Fabaceae) on diabetic ratsPhool Chandra, Mohammad Kaleem, Neetu Sachan, et al.Journal of Enzyme Inhibition and Medicinal Chemistry|July 16, 2021
Synthesis, potential antitumor activity, cell cycle analysis, and multitarget mechanisms of novel hydrazones incorporating a 4-methylsulfonylbenzene scaffold: a molecular docking studyAlaa A-M Abdel-Aziz, Adel S El-Azab, Nawaf A AlSaif, et al.Pharmaceuticals (Basel, Switzerland)|July 29, 2023
Investigation of Novel Benzoxazole-Oxadiazole Derivatives as Effective Anti-Alzheimer's Agents: In Vitro and In Silico ApproachesSaeed Anwar, Wajid Rehman, Rafaqat Hussain, et al.Pharmaceuticals (Basel, Switzerland)|July 30, 2025
Purine-Hydrazone Scaffolds as Potential Dual EGFR/HER2 InhibitorsFatemah S Albalawi, Mashooq A Bhat, Ahmed H Bakheit, et al.Journal of Enzyme Inhibition and Medicinal Chemistry|April 3, 2020
Novel sulindac derivatives: synthesis, characterisation, evaluation of antioxidant, analgesic, anti-inflammatory, ulcerogenic and COX-2 inhibition activityMashooq A Bhat, Mohamed A Al-Omar, Nawaf A Alsaif, et al.Journal of Enzyme Inhibition and Medicinal Chemistry|March 19, 2020
Synthesis, antitumor activity, and molecular docking study of 2-cyclopentyloxyanisole derivatives: mechanistic study of enzyme inhibitionWalaa M El-Husseiny, Magda A-A El-Sayed, Adel S El-Azab, et al.Journal of Enzyme Inhibition and Medicinal Chemistry|August 3, 2021
Design, synthesis, docking, ADMET studies, and anticancer evaluation of new 3-methylquinoxaline derivatives as VEGFR-2 inhibitors and apoptosis inducersMohammed M Alanazi, Ibrahim H Eissa, Nawaf A Alsaif, et al.Journal of Enzyme Inhibition and Medicinal Chemistry|May 31, 2021
Discovery of new VEGFR-2 inhibitors based on bis([1, 2, 4]triazolo)[4,3-<i>a</i>:3',4'-<i>c</i>]quinoxaline derivatives as anticancer agents and apoptosis inducersNawaf A Alsaif, Mohammed S Taghour, Mohammed M Alanazi, et al.Pageof 5